Mr. Hadad is currently Chief Intellectual Property Counsel, as well as lead counsel to the Research & Early Development and Global Pharmaceutical Supply organizations, at Bristol Myers Squibb, where he has been employed for more than a decade. He has previously worked for other major pharmaceutical companies including, Johnson & Johnson and Schering Plough. He is a board member and was past President of the Intellectual Property Owner’s Association (2018-2019).
Mr. Hadad has lectured on IP issues around the world and has been a leading advocate for a stronger and more predictable global IP system, including testifying before Congress on this topic. Henry has extensive experience in the pharmaceutical industry and particular expertise in intellectual property matters. He earned his law degree from Washington College of Law at American University, and his undergraduate degree in Biology from Haverford College.